Tel: +441519046264 2 KEY POINTS SUMMARY  Sympathetic activation using the cold pressor test (CPT) leads to marked vasodilation in coronary arteries, whereas previous work also demonstrated dilation in carotid arteries.
. Activation of the sympathetic nervous system (SNS) is an important and clinically-relevant prognostic stimulus (Feigl, 1987; Schachinger et al., 2000) . In the coronary arteries, SNS activation can result in a vasoconstrictor (via α 1receptors) or vasodilatory response (via the α 2 -, and β-receptors) (Barbato, 2009) . Whilst vasodilator pathways prevail in healthy volunteers -leading to significant coronary dilation (Doucette et al., 1992; Momen et al., 2009 ) -experimental studies in patients with coronary artery disease demonstrate that stimulation of the SNS mediates vasoconstriction (Nabel et al., 1988; Zeiher et al., 1989) . Importantly, coronary artery responses to SNS activation independently predict future cardiovascular events (Schachinger et al., 2000; Nitenberg et al., 2004b) . These latter studies highlight the potential clinical relevance of examining SNSinduced coronary artery responses. However, serious disadvantages of these measurements include difficulty of assessment and invasiveness of examining coronary arteries.
Evidence that responsiveness of the larger (and more accessable) peripheral arteries may serve as a surrogate measure for coronary artery vasomotor function (Anderson et al., 1995) is supported by close correlation of coronary and forearm artery responses to elevation in shear and/or infusion of vasodilator drugs (Takase et al., 1998; Takase et al., 2005) . Although direct comparisons are lacking, several studies have reported no change in peripheral (i.e., brachial artery) conduit artery diameter upon SNS-activation, suggesting distinct responses between coronary and peripheral conduit arteries to SNS-activation (Harris et al., 2000; Lind et al., 2002; Dyson et al., 2006; Thijssen et al., 2006; Momen et al., 2009) . Interestingly, previous work demonstrated dilation of the more central carotid artery during sympathetic activation (via cold pressor test, CPT) in patients with (risk for) cardiovascular disease and healthy 6 subjects (Rubenfire et al., 2000; van Mil et al., 2016) . To date, no previous study directly compared vasodilator responses between carotid and coronary arteries to distinct SNS activation stimuli. Furthermore, although the vasoconstrictor responses of the coronary arteries via α 1 -receptors have been well documented in humans and animals (Mohrman & Feigl, 1978; Heusch et al., 1984; Kern et al., 1985) , little is known about whether α 1pathways regulate both the coronary and carotid arteries during SNS activation in humans.
Our first aim is to examine whether activation of the SNS, either through the CPT (i.e. a valid test to elevate SNS activity and blood pressure) (Hines & Brown, 1936; Victor et al., 1987) or lower-body negative pressure (LBNP, test that elevates SNS activity, with preserved blood pressure [at least during mild to moderate negative pressures]) (Victor & Leimbach, 1985; Jacobs et al., 1996) , lead to vasodilation in both the coronary and carotid artery. Our second aim was to assess the role of α 1 -receptors to these responses by using an oral, selective α 1receptor blocker (i.e. Prazosin). Based on previous work (van Mil et al., 2016) , we hypothesise that SNS activation will lead to an increase carotid artery diameter and left anterior descending coronary artery velocity (LAD velocity), independent on the test of SNS activation. Furthermore, based on the vasoconstrictive nature of α 1 -receptors, we anticipated that systemic blockade of α 1 -receptors would exaggerate the vasodilator responses to activation of the SNS (i.e. greater increase in CCA diameter and increase in LAD velocity).
METHODS

Ethical approval
This study was approved by the Human Ethics Committee of the University of British Columbia and conformed to the standards set by the Declaration of Helsinki. All volunteers provided written informed consent.
Participants
We recruited 10 healthy male participants (mean age 25±3 years, height 1.78±0.1 m, and weight 76±9 kg). Exclusion criteria were a history of cardiovascular disease (i.e. angina pectoris, myocardial infarction, heart failure), lung disease (i.e. COPD, lung cancer), brain disease (i.e. stroke, dementia), presence of Raynaud's phenomenon, scleroderma, chronic pain
and/or open wounds on the upper extremities, obesity (body mass index >30 kg/m 2 ), diabetes mellitus type 1 or 2, history of smoking, or elevated blood pressure (systolic >130 mmHg; diastolic >85 mmHg).
Experimental design
All participants reported to our laboratory for a single visit. They were asked to abstain from strenuous exercise for 24 hours and abstain from dietary products known to affect endothelial function for ≥18 hours prior to the testing session (i.e. vitamin C, caffeine and alcohol).
Moreover, participants were asked to fast for ≥2 hours, adapted from existing guidelines to assess peripheral vascular function (Thijssen et al., 2011) . Participants rested in the supine position for >15 minutes on a bed in a temperature-controlled room (23±1°C). Subsequently, participants underwent LBNP and two CPT, in a randomly assigned order, with 45-minutes rest between tests. All tests involved simultaneous assessment of common carotid artery (CCA) diameter and velocity (ultrasound) and left anterior descending (LAD) coronary artery velocity (echocardiography) before (across a 1-minute baseline) and during sympathetic stimulation. The protocol was repeated 90-minutes after oral administration of Prazosin (i.e. α 1 -adrenergic receptor antagonist, 0.05mg per kg body weight) (Jones et al., 2011; Atkinson et al., 2015) .
Experimental measures
Common carotid artery diameter and velocity. Left carotid artery diameter and red blood cell velocity were recorded simultaneously and continuously during baseline (1-minute) and sympathetic stimuli (i.e. 3-minutes CPT, and ~18-minutes LBNP). Carotid artery image acquisition was performed using a 10-MHz multifrenquency linear array handheld probe attached to a high resolution ultrasound machine (15L4, Terason T3200, Burlington, MA, USA). When an optimal image was found, 2-3 cm proximal from the bifurcation, the probe was held stable and the ultrasound parameters were set to optimise the longitudinal, B-mode image of the lumen-arterial wall interface. Continuous pulsed wave Doppler velocity assessments were also obtained and were collected at the lowest possible insonation angle (always <60º). Assessment was performed by an experienced sonographer (ACCM), whom has a hour-to-hour reproducibility (i.e. coefficient of variation) of CCA baseline diameter of 5% and reproducibility of 6% for the CCA diameter response to the cold pressor test (van Mil et al., 2016) .
Coronary artery velocity. Before and during both CPT and LBNP, the left anterior descending (LAD, cm) coronary artery velocity was examined using transthoracic ultrasound. This assessment was performed simultaneously with CCA diameter and velocity responses. All echocardiographic measurements were collected by a trained sonographer (MS) on a commercially available ultrasound system (Vivid E9; GE, Fairfield, CT) using a broadband M5S 5 MHz or a 3V 3D-array transducer. Participants assumed a left lateral position to allow for data collection. The LAD was imaged using a modified parasternal short axis view from the fourth or fifth left intercostal space, and was assessed using pulsed-wave Doppler. The transducer was positioned such that a 2-to 3-mm segment of the LAD was imaged along the long axis, taking care to align the pulse-wave cursor with the length of the vessel. With a sample volume (2.0 mm) positioned over the color Doppler signal in the LAD, measurements of the LAD velocity were collected during the sympathetic tests.
Blood pressure and heart rate. All continuously recorded cardiovascular measurements were acquired at 200 Hz using an analog-to-digital converter (Powerlab/16SP ML 880;
ADInstruments, Colorado Springs, CO, USA) interfaced with a personal computer. Before and during CPT and LBNP, systolic and diastolic blood pressure (SBP and DBP, in mmHg, respectively), stroke volume (SV, ml), rate-pressure product (RPP, HR x SBP, a reliable indicator for myocardial oxygen demand) (Gobel et al., 1978) , and cardiac output (CO, L/min) were continuously measured using non-invasive finger photoplethysmography (Finometer Pro, Finapres medical systems, Amsterdam, Netherlands). Heart rate (HR, beats per minute) was recorded using three-lead electrocardiography, placed in lead II configuration (Bioamp, ML132, ADInstruments, Colorado Springs, CO, USA).
Sympathetic stimuli
Cold pressor test. The cold pressor tests (CPT) consisted of a 3-minute immersion of the left hand in a bucket of ice slush (~4.0°C) (van Mil et al., 2016) . The participant was positioned in supine position on a tilt bed, tilted slightly to the left lateral position (~25-30°), to facilitate arm movement in the bucket of slush without significant movement of the body, and provide adequate coronary assessment. After a 1-minute baseline period, the participants hand was immersed up to the wrist in the ice-slush for 3 minutes. The participant was instructed remain quiet during the CPT to provide for valid CCA assessment. The partial pressures of end-tidal carbon dioxide (P ET CO 2 ) and oxygen (P ET O 2) were clamped at baseline values for the entire duration of the protocol to reduce the potential impact of hyperventilation on the vascular responses, upon an end-tidal forcing approach described extensively elsewhere (Tymko et al., 2016) . To reduce measurement error, CPT procedures were repeated twice and averaged for analyses (van Mil et al., 2016) .
Lower body negative pressure. The participant was positioned in the supine position on a tilt bed, and strapped into a custom-made airtight, lower-body suction chamber at the level of the iliac crest (Tymko, 2016) . The LBNP chamber was then moved from supine position into a left lateral position (~25-30°) to ensure adequate coronary imaging. The lower body negative pressure test consisted of a 5-minute baseline, followed by progressive 2-minute stages, using increments of -10 mmHg, to -80 mmHg or until pre-syncope. LBNP was terminated when a) pre-syncope, defined by a sustained drop in systolic blood pressure <80 mmHg for more than 10 seconds, occurred (Lewis et al., 2014) , or b) on participants request due to the onset of subjective symptoms (e.g. feelings of dizziness, nausea, faintness). During the Prazosin condition, participants were unable to last longer than -40mmHg during the LBNP test. For reliable comparison between the control and drug condition, we chose to only include data until -30mmHg.
Data analysis
Carotid artery responses. Analyses of diameter (cm), blood flow (ml/sec), blood velocity (cm/sec) and shear (s -1 ) were performed using custom-designed edge-detection and walltracking software, which is largely independent of investigator bias, as was extensively described elsewhere (Black et al., 2008) . Baseline diameter, blood flow, blood velocity and shear were calculated as the mean of data acquired across a 1-minute baseline period. For the CPT, data were calculated for 10-second intervals. LBNP data was calculated per 1-minute intervals. Subsequently, offline image analysis involves the identification of the region of interest (ROI), to allow for automated calibration on the B-mode image and velocities on the Doppler assessment (Thijssen et al., 2009) . A ROI is drawn around the optimal B-mode image, in which a pixel-density algorithm automatically identifies the near-and far wall.
Another ROI is drawn around the Doppler waveform, which is synchronized with the B-mode diameter ROI. Ultimately, this allows for blood flow and shear rate calculations (Thijssen et al., 2009) . Peak diameter change was calculated relative to baseline diameter.
Coronary artery responses. All images were exported for offline analysis using commercially available software (EchoPAC Version 13.0; GE Medical, Horten, Norway).
All echocardiographic values represent an average value of three cardiac cycles representing the clearest of five collected images for each experimental stage. The collected waveforms were analyzed to determine mean diastolic velocity (LADVmean, cm/s), peak diastolic velocity (LADVmax, cm/s), and the velocity time integral (VTI, cm). Participants in whom at least 1 image was suboptimal, were excluded prior to analyses (Boulet et al., 2016) .
Blood pressure and heart rate. Analyses of systolic-, and diastolic pressure, heart rate, cardiac output, stroke volume, and the rate-pressure product (RPP) were performed in commercially available software (LabChart V7.1, ADInstruments, Colorado Springs, CO, USA).
Measurements were averaged per 10-second bins for analyses for the CPT, and 1-minute bins for the LBNP analyses. Baseline CPT was averaged over a 3-minute period. Continuous blood pressure measurements were calibrated to automated brachial blood pressure readings during baseline (HEM-775CAN, Omron Healthcare, Bannockburn, IL, USA).
Statistical analyses
All data were presented as mean ± SD unless stated otherwise. 
RESULTS
Carotid vs coronary artery responses: different stimuli.
Cold pressor test. The CPT caused a significant increase in systolic and diastolic blood pressure and the rate-pressure product (RPP), whilst no change was found in stroke volume, heart rate and cardiac output (n=9, Table 1 ). Although the diameter of the CCA increased (2%) significantly during CPT (P<0.001, Figure 1 ), CCA velocity, flow and shear rate did not change significantly across time during CPT (P>0.05, data not shown due to space restrictions). LAD showed a significant increase in maximum velocity (n=6, baseline 0.25±0.03 to peak 0.34±0.02, P<0.05) and VTI (P<0.05, Figure 1 ) during CPT.
Lower body negative pressure. LBNP caused a gradual, but significant increase in heart rate, a decrease in stroke volume and diastolic blood pressure, whilst systolic blood pressure and cardiac output were preserved (n=9, Table 2 ). LBNP caused a significant decrease (-0.8%) in CCA diameter (Figure 2) , whereas no changes were found in CCA velocity, flow and shear (data not shown). Likewise, during LBNP, LAD maximum velocity (n=5, Table 2 ) and peak VTI ( Figure 2) were both reduced. When the CPT-and LBNP-induced changes were pooled (n=20), a significant correlation was found between changes in CCA diameter and LAD peak VTI (r=0.65, P<0.01).
Carotid vs coronary artery response to sympathetic activation: role of α-receptors
Cold pressor test. Prazosin attenuated the increase in blood pressure during CPT, and resulted in a larger increase in cardiac output and RPP during the CPT (n=9, Table 2 ); stroke volume and heart rate responses were unaltered (Table 2) , neither were CCA flow, shear and velocity (data not shown). Following Prazosin administration at baseline, both CCA diameter and higher LAD VTI were elevated (n=6, Figure 3 ). Prazosin significantly abolished the increases in CCA diameter ( Figure 3A ) and LAD peak VTI during the CPT (Figure 3C-D) . Likewise, Prazosin also abolished the CPT-induced increase in LAD mean and maximum velocity (Table 2) .
Lower-body negative pressure. Prazosin exaggerated the increase in heart rate and RPP during LBNP, whilst blood pressure decreased during the Prazosin trial (n=9, Table 2 ). Baseline CCA diameter, flow and velocity were significantly larger following Prazosin adminstration (0.684±0.05 to 0.706±0.05, 10.2±1.6 to 12.0±2.3, and 27.6±5.0 to 30.0±5.5, respectively, all P<0.05). In contrast, no significant difference was found for baseline LAD velocity (n=5, Figure 4 ). Prazosin did not alter the CCA diameter or LAD peak VTI or peak velocity responses during LBNP (up to -30 mmHg; Table 2 , Figure 4 ).
DISCUSSION
We present the following two novel findings. First, activation of the SNS using the CPT significantly increased CCA diameter and coronary artery velocity. In contrast, SNS activation using LBNP mediated a decrease in both CCA diameter and coronary artery velocity. Despite a divergent response to both sympathetic tests, we found a positive relationship between coronary and carotid responses to sympathetic stimulation. Second, systemic blockade of the α 1 -receptors significantly attenuated the dilator response of both the carotid and coronary arteries during the CPT, whilst these changes were unaltered during LBNP. Taken together, we found divergent responses to SNS activation, whilst apparent similarity between carotid and coronary arteries in vascular responses to sympathetic stimulation is present, and the role of α 1 -receptors in mediating these responses seems comparable between arteries. Our observations have clinical relevance, as the common carotid artery may serve as an easy and accessible surrogate for coronary responses to sympathetic stimulation.
Activation of the SNS using a CPT is well known to induce marked coronary artery vasodilation in healthy volunteers (Nabel et al., 1988; Zeiher et al., 1989) . Similarly, in our group of healthy subjects, we found an increase in LAD VTI during CPT. Previous studies found strong agreement between increases in coronary artery blood velocity and blood flow in response to sympathetic stimulation (Doucette et al., 1992; Momen et al., 2009; Monahan et al., 2013) , suggesting that the increase in LAD VTI can be interpreted as the presence of vasodilation. The CPT also resulted in a dilation in the CCA, suggesting similarity between both central artery responses to the CPT. Interestingly, these dilator responses markedly contrast with peripheral artery responses, since brachial or superficial femoral arteries demonstrate negligible diameter changes during CPT (Lind et al., 2002; Dyson et al., 2006) .
Central, eleastic arteries may thus respond differently to SNS activation using the CPT compared to muscular, peripheral arteries. This notion is further supported by observations of abdominal aorta dilation during the CPT (Chandraratna et al., 2009) .
We also examined coronary and carotid artery responses to LBNP; a test known to increase SNS activation, but with blood pressure being maintained around baseline level (Victor & Leimbach, 1985) . In contrast to the CPT, reduction in coronary LAD velocity and a decrease in carotid artery diameter was observed during LBNP. Nonetheless, the presence of coronary artery vasoconstriction during LBNP is in agreement with a previous study that reported a reduction in LAD coronary blood velocity during comparable LBNP levels of -10 and -30 mmHg LBNP (Momen et al., 2009 ). Distinct artery responses to different tests of sympathetic activation have also been reported in peripheral conduit arteries (Dyson et al., 2006) .
Potentially, CPT and LBNP mediate sympathetic activation through different pathways, leading to distinct vascular responses in peripheral and central arteries. Whilst CPT causes an immediate increase in blood pressure (Dyson et al., 2006; Momen et al., 2009) , LBNP mediates a gradual, baroreflex-mediated activation of the sympathetic nervous system that preserves blood pressure. Both sympathetic tests also demonstrate distinct time-dependent changes in circulating catecholamines. For example, there is an immediate elevation in epinephrine and norepinephrine after CPT, whereas elevation in epinephrine and norepinephrine during LBNP seem time-and intensity-dependent (Robertson et al., 1979; Jacobs et al., 1996; Dyson et al., 2006; Momen et al., 2009) . Although further research is warranted to better understand the distinct vascular responses to different sympathetic tests, our data during LBNP provides further evidence that both the carotid and coronary arteries demonstrate similar responses, independent of the sympathetic test.
Under physiological conditions, α 1 -receptors mediate vasoconstriction in the coronary arteries during a sympathetic stimulus (Mudge et al., 1976; Kern et al., 1985) . Indeed, α 1 -receptor blockade has been associated with an increase in baseline LAD velocity as well as an increase in baseline CCA diameter, velocity and blood flow. However, in contrast to our hypothesis, α 1 -blockade attenuated the dilator responses of coronary and carotid arteries during activation of the SNS using the CPT. One potential explanation is that the increase in baseline diameter and/or flow (induced by α 1 -receptor blockade) prevented a further increase upon SNS stimulation. Previous work in peripheral arteries repeatedly demonstrated the presence of a strong, inverse relation between baseline diameter and endothelium-dependent andindependent vasodilator responses (Silber et al., 2001; Thijssen et al., 2008) . In contrast, however, our data does not reveal such a relation between resting diameter and peak responses in the carotid artery diameter (CPT control r=-0.280, Prazosin r=-0.275, LBNP control r=-0.401, Prazosin r=-0.219, all P>0.05). Furthermore, the increase in resting diameter was well below the peak response observed during the CPT. Therefore, although we acknowledge the limations of correlational inferences, CCA and LAD dilation during α 1blockade at baseline does not seem to explain the attenuated vasomotor responses to CPT.
Another potential explanation for our observations may relate to the pharmacological actions of α 1 -receptor blockers. In healthy coronary arteries, vasoconstriction upon sympathetic stimulation is largely mediated via α 1 -receptors, whilst α 2 -receptors play a minor role in these responses (Baumgart et al., 1999) . However, previous studies in both animals and humans found that during α 1 -receptor blockade, SNS activation causes constriction of coronary arterioles which is mediated via activation of α 2 -receptors (Chilian, 1991; Indolfi et al., 1992; Heusch et al., 2000) . Accordingly, blockade of the α 1 -receptors in our study may have yielded stimulation of α 2 -receptors during activation of the SNS using the CPT. Consequently, the vasodilator responses may be affected by the constrictive actions of the α 2 -receptors during the CPT. This hypothesis needs further exploration.
Clinical relevance. Coronary artery responsiveness to SNS stimulation, including the CPT, has shown a strong predictive ability for future cardiovascular disease and/or events (Schachinger et al., 2000; Nitenberg et al., 2004a; Nitenberg et al., 2004b) . The similarity in vasomotor responsiveness between coronary and carotid arteries suggests that the carotid artery may serve as a surrogate measure for coronary vascular responses to SNS stimulation.
An important advantage of measuring the carotid artery is its easy accessibility. This warrants future studies to further explore the potential clinical use of examining CCA responses to SNS stimulation.
Methodological considerations. The rate-pressure product, an indirect measure of myocardial oxygen demand, increased in both tests, whilst α 1 -receptor blockade caused a further increase.
This increase in RPP, and thus increase in myocardial work effort, may interfere with direct responses of the coronary vasculature to sympathetic stimuli. However, due to the indirectness of the measurement of myocardial workload (Boulet et al., 2016) , it remains to be clarified to what extend this influenced our results. A strength of our study was that we controlled for end-tidal gases at baseline values, during both CPT and LBNP, and the α 1receptor blockade condition. Fluctations and alterations in P ET CO 2 are known to directly influence the diameter of the CCA (Sato et al., 2012) and LAD VTI (Boulet et al., 2016) .
Following our alpha-1 blockade, which directly affects mean arterial pressure and ventilatory regulation during sympathetic activation, clamping P ET CO 2 and P ET O 2 to baseline values reduced the possible interference with our carotid and coronary artery responses. A limitation in our study was that subjects reached pre-syncope at -30 or -40 mmHg when LBNP was combined with Prazosin. Given the gradual changes in vasomotor responses during the LBNP, we could only compare data between both sessions up to -30 mmHg. Another limitation was that, due to the suction of the LBNP box, movement of the participants prevented valid assessment of coronary responses in 5 participants. Whilst these limit the ability for detailed assessment of the role of the α-receptors in large sample, data clearly demonstrates similarity between coronary and carotid artery responses.
To summarize, despite sympathetic tests mediating distinct vascular responses, our data demonstrates strong similarity between coronary and carotid artery reactivity in response to the cold pressor test (i.e. dilation) and lower body negative pressure (i.e. constriction).
Additionally, blockade of the α 1 -receptors significantly attenuated the dilator responses in both arteries during the CPT, whilst no changes were found during LBNP, suggesting a similar role for α-receptors to contribute to vasomotor responses in coronary and carotid arteries. The similarity between carotid and coronary arteries may have future clinical relevance when using the carotid artery as a surrogate for coronary arteries. 
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